|
NXTC NextCure Inc 1661059 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-14,892,000.00 |
| Balance Sheet |
|
Current Assets
|
$22,255,000.00 |
|
Assets
|
$22,620,000.00 |
|
Current Liabilities
|
$6,413,000.00 |
|
Liabilities
|
$10,471,000.00 |
|
Equity
|
$12,149,000.00 |
|
Shares Out
|
4068951.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-23,078,000.00 |
|
Investing Cash Flow
|
$11,086,000.00 |
| Market Analysis |
Market Cap
|
$25,430,943.75 |
|
Price
|
$6.25 |
|
BVPS
|
2.99 |
|
PB
|
2.09 |
|
EPS
|
-2.80 |
|
FCF
|
$-23,552,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:01 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:51 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NXTC documents filed with the SEC.
NXTC Filings
Clear
